Search research articles
Contact Us
Filters
Showing results (41-50 of 81) with videos related to
Page
of 9
Sort By:
European Journal of Clinical Pharmacology
|
January 1, 1986
The effect of ranitidine and cimetidine on imipramine disposition
B G Wells, J A Pieper, T H Self, et al.
Lancet (London, England)
|
February 18, 1984
Methotrexate systemic clearance influences probability of relapse in children with standard-risk acute lymphocytic leukaemia
W E Evans, W R Crom, C F Stewart, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1993
Disposition of total and unbound etoposide following high-dose therapy
T L Schwinghammer, R A Fleming, C S Rosenfeld, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 31, 2000
Biochemical correlates of temozolomide sensitivity in pediatric solid tumor xenograft models
D S Middlemas, C F Stewart, M N Kirstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Phenytoin alters the disposition of topotecan and N-desmethyl topotecan in a patient with medulloblastoma
W C Zamboni, A J Gajjar, R L Heideman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 1998
Phase I study of topotecan in combination with cyclophosphamide in pediatric patients with malignant solid tumors: a Pediatric Oncology Group Study
R L Saylors, C F Stewart, W C Zamboni, et al.
Cancer Chemotherapy and Pharmacology
|
September 27, 2014
Phase I dose escalation and pharmacokinetic study of oral gefitinib and irinotecan in children with refractory solid tumors
R C Brennan, W Furman, S Mao, et al.
Chest
|
December 1, 1990
Inhaled albuterol and oral prednisone therapy in hospitalized adult asthmatics. Does aminophylline add any benefit?
T H Self, N Abou-Shala, R Burns, et al.
Clinical Pharmacology and Therapeutics
|
March 1, 1983
Methotrexate cerebrospinal fluid and serum concentrations after intermediate-dose methotrexate infusion
W E Evans, P R Hutson, C F Stewart, et al.
Drug Intelligence & Clinical Pharmacy
|
November 1, 1982
Disposition of intermediate-dose methotrexate in children with acute lymphocytic leukemia
W E Evans, C F Stewart, P R Hutson, et al.
Page
of 9
Search research articles
Search
Showing results (41-50 of 81) with videos related to
Sort By:
Page
of 9
European Journal of Clinical Pharmacology
|
January 1, 1986
The effect of ranitidine and cimetidine on imipramine disposition
B G Wells, J A Pieper, T H Self, et al.
Lancet (London, England)
|
February 18, 1984
Methotrexate systemic clearance influences probability of relapse in children with standard-risk acute lymphocytic leukaemia
W E Evans, W R Crom, C F Stewart, et al.
Cancer Chemotherapy and Pharmacology
|
January 1, 1993
Disposition of total and unbound etoposide following high-dose therapy
T L Schwinghammer, R A Fleming, C S Rosenfeld, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 31, 2000
Biochemical correlates of temozolomide sensitivity in pediatric solid tumor xenograft models
D S Middlemas, C F Stewart, M N Kirstein, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
May 14, 1998
Phenytoin alters the disposition of topotecan and N-desmethyl topotecan in a patient with medulloblastoma
W C Zamboni, A J Gajjar, R L Heideman, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
March 21, 1998
Phase I study of topotecan in combination with cyclophosphamide in pediatric patients with malignant solid tumors: a Pediatric Oncology Group Study
R L Saylors, C F Stewart, W C Zamboni, et al.
Cancer Chemotherapy and Pharmacology
|
September 27, 2014
Phase I dose escalation and pharmacokinetic study of oral gefitinib and irinotecan in children with refractory solid tumors
R C Brennan, W Furman, S Mao, et al.
Chest
|
December 1, 1990
Inhaled albuterol and oral prednisone therapy in hospitalized adult asthmatics. Does aminophylline add any benefit?
T H Self, N Abou-Shala, R Burns, et al.
Clinical Pharmacology and Therapeutics
|
March 1, 1983
Methotrexate cerebrospinal fluid and serum concentrations after intermediate-dose methotrexate infusion
W E Evans, P R Hutson, C F Stewart, et al.
Drug Intelligence & Clinical Pharmacy
|
November 1, 1982
Disposition of intermediate-dose methotrexate in children with acute lymphocytic leukemia
W E Evans, C F Stewart, P R Hutson, et al.
Page
of 9